Indonesia In-Vitro Diagnostics Market is predicted to reach USD 2.04 Billion by 2030

According to the study by Next Move Strategy Consulting, the Indonesia In-Vitro Diagnostics Market size is predicted to reach USD 2.04 billion, at a CAGR of 7.5% by 2030.

Request a FREE Sample: https://www.nextmsc.com/indonesia-in-vitro-diagnostics-market/request-sample

The advancements in healthcare infrastructure with continuous efforts by both central and regional government in Indonesia, is driving the growth of the in-vitro diagnostics market.

The prevalence of cancer in the country boosts the demand for advanced diagnostics solutions.

The promising players operating in the Indonesia in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.